7月24日深交所举办第十七期“创享荟”活动聚焦合成生物产业发展邀请华大基因、川宁生物、康弘药业、三元生物、卫光生物、金城药业、华恒生物等合成生物领域相关上市公司代表深圳市合成生物产业私募基金、建设银行等机构代表中科院深圳先进技术研究院合成生物研究所等科研机构代表共话合成生物产业发展支持高水平科技自立自强助力培育壮大新质生产力。

智通财经07-24

7月24日深交所举办第十七期“创享荟”活动聚焦合成生物产业发展邀请华大基因、川宁生物、康弘药业、三元生物、卫光生物、金城药业、华恒生物等合成生物领域相关上市公司代表深圳市合成生物产业私募基金、建设银行等机构代表中科院深圳先进技术研究院合成生物研究所等科研机构代表共话合成生物产业发展支持高水平科技自立自强助力培育壮大新质生产力。“创享荟”围绕合成生物产业相关技术发展趋势、政府与资本市场如何助力合成...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2453006341?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-07-24 20:01","share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","id":"2453006341","market":"sh","top_or_hot":-1,"title":"7月24日深交所举办第十七期“创享荟”活动聚焦合成生物产业发展邀请华大基因、川宁生物、康弘药业、三元生物、卫光生物、金城药业、华恒生物等合成生物领域相关上市公司代表深圳市合成生物产业私募基金、建设银行等机构代表中科院深圳先进技术研究院合成生物研究所等科研机构代表共话合成生物产业发展支持高水平科技自立自强助力培育壮大新质生产力。","media":"智通财经","content":"<div>\n<p>7月24日深交所举办第十七期“创享荟”活动聚焦合成生物产业发展邀请华大基因、川宁生物、康弘药业、三元生物、卫光生物、金城药业、华恒生物等合成生物领域相关上市公司代表深圳市合成生物产业私募基金、建设银行等机构代表中科院深圳先进技术研究院合成生物研究所等科研机构代表共话合成生物产业发展支持高水平科技自立自强助力培育壮大新质生产力。“创享荟”围绕合成生物产业相关技术发展趋势、政府与资本市场如何助力合成...</p>\n\n<a href=\"https://www.zhitongcaijing.com/immediately.html?type=usstock\">网页链接</a>\n\n</div>\n","source":"live_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7x24快讯</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7x24快讯\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-24 20:01 北京时间&nbsp;&nbsp;&nbsp;<a href=https://www.zhitongcaijing.com/immediately.html?type=usstock><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>7月24日深交所举办第十七期“创享荟”活动聚焦合成生物产业发展邀请华大基因、川宁生物、康弘药业、三元生物、卫光生物、金城药业、华恒生物等合成生物领域相关上市公司代表深圳市合成生物产业私募基金、建设银行等机构代表中科院深圳先进技术研究院合成生物研究所等科研机构代表共话合成生物产业发展支持高水平科技自立自强助力培育壮大新质生产力。“创享荟”围绕合成生物产业相关技术发展趋势、政府与资本市场如何助力合成...</p>\n\n<a href=\"https://www.zhitongcaijing.com/immediately.html?type=usstock\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0183","symbol_name":"MSCI概念","start_time":0,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","article_id":"2453006341","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2453006341","pubTimestamp":1721822474,"sourceInfo":{"source_id":"live_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"7月24日深交所举办第十七期“创享荟”活动聚焦合成生物产业发展邀请华大基因、川宁生物、康弘药业、三元生物、卫光生物、金城药业、华恒生物等合成生物领域相关上市公司代表深圳市合成生物产业私募基金、建设银行","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"300676":"华大基因","301206":"三元生物","301301":"川宁生物","601939":"建设银行","688639":"华恒生物","BK0183":"MSCI概念","LU1997244956.HKD":"ALLIANZ CHINA A-SHARES \"AT\" (HKD) ACC A","LU0043850808.USD":"HSBC GIF ASIA EX JAPAN EQUITY \"AD\" INC","LU0634319403.HKD":"ALLIANZ HONG KONG EQUITY \"AT\" (HKD) ACC","HK0000320264.USD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (USD) ACC","BK0197":"中小创蓝筹","LU0516422440.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"A\" (USD) ACC","IE00B0JY6N72.USD":"PINEBRIDGE GLOBAL EMERGING MARKETS FOCUS EQUITY \"A\" (USD) ACC","LU0293314216.USD":"ALLIANZ GEM EQUITY HIGH DIVIDEND \"A\" (USD) ACC","LU1997245094.SGD":"安联神州A股基金AT Acc SGD","LU0348735423.USD":"ALLIANZ HONG KONG EQUITY \"A\" (USD) INC","BK0042":"基因检测","LU0287142896.SGD":"Fidelity China Focus A-SGD","LU0096374516.USD":"CT (LUX) I ASIA EQUITY INCOME \"DU\" (USD) ACC","LU0259732245.USD":"EASTSPRING INVESTMENTS DRAGON PEACOCK A","LU1997245177.USD":"安联神洲A股基金","LU0572944931.SGD":"Janus Henderson Horizon China Opportunities A2 SGD","LU0348805143.USD":"ALLIANZ ENHANCED ALL CHINA EQUITY \"A\" (USD) INC","LU0061477393.USD":"CT (LUX) I ASIA EQUITY INCOME \"AU\" (USD) ACC","IE00B3M56506.USD":"NEUBERGER BERMAN EMERGING MARKETS EQUITY \"A\" (USD) ACC","BK0015":"沪股通50","LU0163747925.USD":"EASTSPRING INVESTMENTS ASIAN EQUITY A ACC","LU0348825331.USD":"ALLIANZ CHINA EQUITY \"A\" (USD) INC","BK1231":"综合性银行","LU0084288322.USD":"Natixis Asia Equity RD USD","BK1560":"内银股","LU0633140560.USD":"AB EMERGING MARKET MULTI ASSET PORTFOLIO \"A\" (USD) ACC","BK0221":"专业技术","LU2495084118.USD":"ALLIANZ CHINA A-SHARES \"ATH\" (USDHDG) ACC","IE00BWDBJ730.SGD":"Legg Mason QS - MV Asia Pacific ex Japan Equity Growth and Income A Mdis SGD-H Plus","LU0417516902.SGD":"Allianz China Equity Cl AT Acc SGD","LU0149721374.USD":"HSBC GIF HONG KONG EQUITY \"AD\" INC","00939":"建设银行","LU0348827113.USD":"ALLIANZ RCM CHINA \"AT\" ACC","BK0239":"医药制造","LU0052750758.USD":"富兰克林中国基金A Acc","BK1521":"挪威政府全球养老基金持仓","LU0173614495.USD":"富达中国焦点A","002880":"卫光生物","HK0000320223.HKD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (HKD) ACC","LU0417516738.SGD":"Allianz Hong Kong Equity AT Acc SGD","LU0359201612.USD":"贝莱德中国基金A2","BK0175":"白马股","002773":"康弘药业","03143":"华夏香港银行股"},"translate_title":"On July 24, the Shenzhen Stock Exchange held the 17th \"Creation and Enjoyment\" event focusing on the development of the synthetic biology industry and inviting BGI and Twinings Biotech","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300676":1,"301206":1,"301301":1,"601939":1,"688639":1,"002880":1,"00939":1,"002773":1,"03143":0.6},"content_text":"7月24日深交所举办第十七期“创享荟”活动聚焦合成生物产业发展邀请华大基因、川宁生物、康弘药业、三元生物、卫光生物、金城药业、华恒生物等合成生物领域相关上市公司代表深圳市合成生物产业私募基金、建设银行等机构代表中科院深圳先进技术研究院合成生物研究所等科研机构代表共话合成生物产业发展支持高水平科技自立自强助力培育壮大新质生产力。“创享荟”围绕合成生物产业相关技术发展趋势、政府与资本市场如何助力合成生物新质生产力发展、如何解决产业化与规模化问题等主题进行对话。发言嘉宾从不同角度阐述了对合成生物产业发展的观点看法分享了上市公司运用资本市场工具成长壮大的做法、经验和案例并就合成生物产业化存在的难点和解决方案展开讨论。（深交所）","kind":null,"is_publish_news":false,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.3","shortVersion":"4.28.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2453006341"}